Ziemer Ophthalmics' femtosecond laser receives FDA clearance

Article

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

The system's state-of-the-art laser technology generates shorter, smaller, lower-energy infrared laser pulses that dissect corneal tissue with unprecedented smoothness and precision, according to the company.

Shipment of the system, which designed for a wide range of applications in corneal surgery, is expected in June 2006.

For more information, visit Ziemer Ophthalmics at Booth 1010.

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.